Oncology Nursing Forum back issues from March 2009:
Brother can you spare a ... page?(Editorial)
Mar 01, 2009; ... I have just returned from the Oncology Nursing Society's (ONS's) 10th National Conference on Cancer Nursing Research that was held in Orlando, FL. I find this particular meeting an inspiring few days, chock-full of examples of the best and brightest oncology nurses involved in research, ...
"Being nice" requires education and enforcement.(Letter to the editor)
Mar 01, 2009; ... I read with interest Rose Mary Carroll-Johnson's (2008) editorial "Be Nice!" It made me think about our current practice environment and how it has evolved over the years. Although handling interpersonal conflict and working with disgruntled and at times intimidating colleagues have been ...
Editor's note.(Editorial)
Mar 01, 2009 ... I received a number of letters of support for the opinions I expressed in my July 2008 editorial, "Shtick or Inspiration?" (volume 35, issue 4), about the types of keynote speakers the Oncology Nursing Society (ONS) chooses for its national meetings. Many others expressed similar opinions ...
Congress opening session should feature clinical speaker.(Letter to the editor)
Mar 01, 2009; ... THANK YOU SO MUCH for putting into elegant words an issue that I have complained about for years and that I always put on my Congress evaluation. Your editorial "Shtick or Inspiration?" expressed my thoughts perfectly. Oncology nurses want to be considered "professional," and yet, year ...
An area for improvement.(Letter to the editor)
Mar 01, 2009; ... Just wanted to tell you that I really enjoyed your editorial in the July 2008 issue. I was unable to attend Congress, but I always look forward to kicking off Congress with a great inspirational speaker. It sounds like that didn't happen. I also concur with you that this is a very ...
Bring back the thrill of opening ceremony.(Letter to the editor)
Mar 01, 2009; ... I want to thank you for your editorial in the July 2008 issue. You have articulated what I have written in my evaluations for the past several years about opening ceremonies. That year was particularly annoying. There was no reason to reference war (!), fighting, wing "man," or cockpit--a ...
Congress speaker highlighted issue of futile care.(LETTERS TO THE EDITOR)(Report)
Mar 01, 2009; ... I did not attend the Philadelphia Congress, but what you stated about keynote addresses rang true for me attending the Las Vegas Congress, where I listened to Joe Caruso shtick about himself as a younger person with testicular cancer and how he was encouraged to keep seeking treatment ...
Policy regarding letters to the editor.(Letter to the editor)
Mar 01, 2009 ... Selection of letters to be published in Letters to the Editor is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing. A letter that questions, criticizes, or responds ...
Oncology Nurse sees profession through the eyes of a patient.(Letter to the editor)
Mar 01, 2009; ... I look forward to your insightful editorial with each issue of the Forum. The July 2008 editorial impressed me enough to respond. I have not attended Congress since 1993 so I cannot comment on the content of the keynote address(es). However, I agree with your assessment of the issues that ...
Oncology Nursing Society member appointed Johns Hopkins University distinguished service chair.(PEOPLE & EVENTS)(Brief article)
Mar 01, 2009; ... Johns Hopkins University appointed Oncology Nursing Society (ONS) member Lillie D. Shockney, RN, BS, MAS, the Distinguished Service Chair, making her the first woman and nurse to hold the position. A special awards dinner was held in her honor, where she received a plaque from Edward D ....
ONS member named Kenneth E. Morehead Endowed Chair in nursing and associate dean for research.(PEOPLE & EVENTS)(oncology nursing forum)(Brief article)
Mar 01, 2009; ... Marlene Cohen, PhD, RN, FAAN, joined the College of Nursing at the University of Nebraska Medical Center in Omaha as the prestigious Kenneth E. Morehead Endowed Chair in Nursing. In the position, Cohen will focus on her nationally known program of improving cancer care. Cohen also became ...
ONS members win Roberta S. Abruzzese Publishing Award.(PEOPLE & EVENTS)(Oncology Nursing Forum)(Brief article)
Mar 01, 2009; ... ONS members Morris A. Magnan, PhD, RN, and JoAnn Maklebust, MSN, APRN, BC, AOCN[R], FAAN, were awarded the Gaymar Industry 2008 Roberta S. Abruzzese Publishing Award, presented at the 23rd Annual Clinical Symposium on Advances in Skin and Wound Care in Las Vegas, NV. Magnan and Maklebust ...
ONS member to give 29th Helen Nahm Lecture.(PEOPLE & EVENTS)(Oncology Nursing Forum)(Brief article)
Mar 01, 2009; ... ONS member Linda Sarna, RN, DNSc, FAAN, will be the 29th Helen Nahm Lecturer. A graduate of the University of California, San Francisco doctoral program in nursing science and a professor in the School of Nursing at the University of California, Los Angeles, Sarna has been involved in ...
ONS member recognized by Connecticut Governor.(PEOPLE & EVENTS)(Brief article)
Mar 01, 2009; ... Linda Versea, APRN, a nurse practitioner and oncology research coordinator in the Whittingham Cancer Center at Norwalk Hospital, is leading a statewide effort called the "Clinical Trials Initiative." Her efforts were recognized by Governor Jodi Rell (R), who, for the second consecutive ...
Joint Commission appoints Mark G. Pelletier.(PEOPLE & EVENTS)(Brief article)
Mar 01, 2009; ... The Joint Commission announced the appointment of Mark G. Pelletier, RN, MS, as the executive director for Hospital Programs and Accreditation and Certification Services. Pelletier is a healthcare executive with more than 20 years of experience. He most recently was the senior vice ...
Breast cancer research initiative to launch.(PEOPLE & EVENTS)(Brief article)
Mar 01, 2009; ... The Dr. Susan Love Research Foundation and the Avon Foundation launched the Love/Avon Army of Women, a groundbreaking initiative that will partner women with breast cancer researchers to find the key to what causes breast cancer and take science beyond a cure to prevention. Through the new ...
Alex's Lemonade Stand Foundation announces 2008 nursing grant recipients.(PEOPLE & EVENTS)(Brief article)
Mar 01, 2009; ... Alex's Lemonade Stand Foundation (ALSF), a leader driving research for pediatric cancer, announced the awarding of the 2008 Nursing Grants to four institutions across the country: Children's Hospital of Philadelphia in Pennsylvania; Children's Hospital and Regional Medical Center in ...
Educational parties as a strategy to promote breast health awareness and screening in underserved female populations.(LEADERSHIP & PROFESSIONAL DEVELOPMENT)(Report)
Mar 01, 2009; ... Nursing professionals involved in institutional and community outreach efforts to improve breast health are experiencing an increasing need for innovative strategies to attract women to participate in early-detection and screening programs. Specifically, many programs have been developed ...
Unanticipated toxicity to capecitabine.(CLINICAL CHALLENGES)(Report)
Mar 01, 2009; ... A 63-year-old African American woman, L.L., was diagnosed with hormone-negative, HER2-negative, stage IIIa breast cancer 18 months ago. Following a left modified radical mastectomy with immediate reconstruction, L.L. was treated with dose-dense adriamycincyclophosphamide followed by ...
Clinical highlights: dihydropyrimidine dehydrogenase deficiency.(CLINICAL CHALLENGES)(Report)
Mar 01, 2009 ... Definition Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive metabolic disorder in which DPD activity is absent or significantly decreased. DPD is an enzyme involved in the metabolism of uracil and thymine, components of 5-fluorouracil (5-FU) (Etienne et ...
Body image perceptions in men with prostate cancer.(Article)(Report)
Mar 01, 2009; ... Prostate cancer is the second most common type of cancer among men in the United States, after skin cancer. The American Cancer Society (ACS) estimated that more than 186,320 new cases of prostate cancer were diagnosed in the United States in 2008 (Jemal et al., 2008), representing 33% of ...
Survivor loneliness of women following breast cancer.(Article)(Report)
Mar 01, 2009; ... In the years beyond diagnosis and acute treatment, the physical, emotional, and social effects of breast cancer may create ongoing challenges and crises that trigger the acute experience of loneliness. Women live with physical reminders (e.g., scars, sweats and hot flashes, fatigue, ...
Case-control study to evaluate predictors of lymphedema after breast cancer surgery.(Article)(Clinical report)
Mar 01, 2009; ... In 2008, more than 182,000 women were diagnosed with breast cancer, and 88% of those women will survive at least five years (Jemal et al., 2008). Lymphedema is a common problem for patients diagnosed with breast cancer, with an estimated 6%-35% developing it sometime after breast cancer ...
Fatigue and physical activity in older patients with cancer: a six-month follow-up study.(Article)(Report)
Mar 01, 2009; ... Cancer is predominantly a disease affecting older patients. Forty-two percent of new cancer cases in Canada occur among patients aged 70 years or older; 27% occur in Canadian patients aged 60-69 years (Canadian Cancer Society/National Cancer Institute of Canada, 2008). Cancer-related ...
Gay and lesbian patients with cancer.(Research Brief)(Report)
Mar 01, 2009; ... The disease trajectory in cancer involves a complex system of treatment choices, multiple treatments over an extended period of time, and significant physical and emotional side effects that impact people from all demographics. However, little published research has explored the cancer ...
The relationships among physiologic variables, quality of life, and fatigue in patients with multiple myeloma.(Article)(Report)
Mar 01, 2009; ... Fatigue is a symptom with several possible etiologic factors related to disease and treatment, including low hemoglobin (hgb), nutritional deficiencies, cytokines, cachexia, tumor burden, anxiety, depression, sleep disturbance, physical activity, and unmanaged symptoms (Ahlberg, Ekman, ...
Complementary and alternative medicine: oncology nurses' knowledge and attitudes.(Article)(Survey)
Mar 01, 2009; ... According to the National Center for Complementary and Alternative Medicine ([NCCAM], 2009), complementary and alternative medicine (CAM) "is a group of diverse medical and healthcare systems, practices, and products that are not presently considered to be part of conventional medicine." ...
Management of temozolomide toxicity by nurse practitioners in neuro-oncology.(Journal Club Article)
Mar 01, 2009; ... Patients with gliomas are confronted with a disease with a poor prognosis and hardly any chance of cure. Median survival of such patients depends on a number of independent prognostic factors, including age, neurologic condition, cognitive function, tumor type, and tumor size. Clinically, ...
Reducing central venous catheter-related bloodstream infections in children with cancer.(Article)(Report)
Mar 01, 2009; ... Children with cancer who have a central venous catheter (CVC) are at increased risk for bloodstream infections. Aseptic technique when using and caring for a CVC can decrease the chance of contamination in this patient population. Staff education on adherence to aseptic technique and ...
Cetuximab and panitumumab mystery solved.(PHARMACY CORNER)(Report)(Brief article)
Mar 01, 2009; ... Research has provided insight regarding why cetuximab (Erbitux[R], Bristol-Myers Squibb, Imclone) works so well with some patients while, at the same time, has little or no benefit for patients with colon cancer testing positive for epidermal growth factor receptor (EGFR) overexpression ....
Denileukin diftitox receives approval.(PHARMACY CORNER)(Brief article)
Mar 01, 2009; ... Denileukin diftitox (Ontak[R], Eisai Medical Research) has received full U.S. Food and Drug Administration (FDA) approval in the treatment of persistent or recurrent cutaneous T-cell lymphoma (CTCL) expressing the CD25 component of the interleukin (IL)-2 receptor (CD25+). CTCL is a rare ...
Bendamustine hydrochloride now used to treat indolent B-cell non-hodgkin lymphoma.(PHARMACY CORNER)(Report)
Mar 01, 2009; ... Previously approved in the t re a tment of chronic lymphocytic leukemia (CLL), the alkylating agent bendamustine hydrochloride (Treanda [R], Cephalon) has received FDA approval for the treatment of indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months ...
Accelerated approval granted for eltrombopag.(PHARMACY CORNER)(Brief article)
Mar 01, 2009; ... The FDA has granted acclerated approval to a second thrombopoiesis stimulating agent, eltrombopag (Promacta[R], GlaxoSmithKline) for the treatment of chronic immune thrombocytopenic purpura that has not responded to the standard treatments of corticosteroids, immunoglobulins, or ...
Tapentadol hydrochloride treats moderate to severe pain.(PHARMACY CORNER)(Brief article)
Mar 01, 2009; ... Tapentadol hydrochloride (Johnson & Johnson Pharmaceutical), an immediate release analgesic with mu-opioid agonist and norepinephrine reuptake inhibitor properties, has received FDA approval for the treatment of moderate-to-severe acute pain in adults. The drug comes in 50, 75, and 100 mg ...
Plerixafor mobilizes stem cells for transplantation.(PHARMACY CORNER)(Brief article)
Mar 01, 2009; ... The FDA has granted approval for plerixafor (Mozobil[TM], Genzyme Corp.) to be used in conjunction with granulocyte-colony--stimulating factor to mobilize stem cells in preparation for autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma and multiple ...
Changes made to efalizumab.(SAFETY CONCERNS)(Brief article)
Mar 01, 2009; ... Labeling changes for the recombinant humanized IgG1 monoclonal antibody efalizumab (Raptiva[R], Genentech) include warnings regarding life-threatening infections, such as bacterial sepsis, viral meningitis, invasive fungal infections, and progressive multifocal leukoencephalopathy ....
Phenytoin and fosphenytoin sodium use carries risk.(SAFETY CONCERNS)(Brief article)
Mar 01, 2009; ... According to the FDA, preliminary data suggest phenytoin (Dilantin[R], Pfizer) and fosphenytoin sodium (Cerebyx[R], Pfizer) use carries an increased risk of Stevens Johnson Syndrome and toxic epidermal necrolysis in patients testing positive ...
Bevacizumab may increase risk of venous thromboembolism.(SAFETY CONCERNS)(Report)(Brief article)
Mar 01, 2009; ... A review of dat a from 7,956 patients with cancer in 15 randomized, controlled trials revealed an increased incidence in venous thromboembolism in patients treated with bevacizumab (Avastin[R], Genentech) compared to patients in control arms of the trials (relative risk = 1.33, p < 0.001) ...
Workgroup suggests smoking be added as indication for pneumococcal vaccination.(NOTEWORTHY)(Brief article)
Mar 01, 2009; ... Noting a prevalence of invasive pneumococcal disease similar to that of high-risk asthmatics, the Advisory Committee of Immunization Practices (ACIP) Pneumococcal Vaccines Workgroup has recommended that ...
Tick-borne infection reported.(NOTEWORTHY)(Report)(Brief article)
Mar 01, 2009; ... A confirmed case of red blood cell transfusion-related infection with Anaplasma phagocytophilum has been reported by the Centers for Disease Control and Prevention (CDC). A. phagocytophilum is a tick-borne infection that causes anaplasmosis. Polymerase chain reaction assays frequently are ...
No reduced cancer benefit found with the use of folic acid, vitamin [B.sub.6], and vitamin [B.sub.12].(NOTEWORTHY)(Brief article)
Mar 01, 2009; ... The Women's Antioxidant and Folic Acid Cardiovascular (WAFAC) study (Zhang et al., 2008) noted no benefit in reducing cancer risk through the use of folic acid, vitamin [B.sub.6], and vitamin [B.sub.12]. The study examined cancer incidence in women at high risk for cardiovascular disease, ...
Vitamin D use did not reduce breast cancer.(NOTEWORTHY)(Report)(Brief article)
Mar 01, 2009; ... A large randomized, double-blinded, placebo-controlled trial failed to demonstrate a reduction in breast cancer incidence with daily supplementation of 1,000 mg calcium plus 400 IU vitamin D3 in postmenopausal women followed over an average of seven years (N = 36,282) (Chlebowski et al., ...
Late congestive heart failure may occur one year after stem cell transplantation.(NOTEWORTHY)(Report)(Brief article)
Mar 01, 2009; ... The development of congestive heart failure (CHF) in patients who received hematopoietic stem cell transplantations may occur even one year after transplantation. Interested in identifying independent risk factors, Armenian et al. (2008) examined data from 60 patients out of a cohort of ...
Docking station helps reduce risk of infection in tubing.(PRODUCTS)
Mar 01, 2009; ... Reuse of IV administration sets for intermittent dosing schedules requires the application of a sterile cap to the end of the tubing to prevent contamination when the set is not in use. An alternative to single-use sterile caps is the PadLock Set Saver[R] (Baxa Corporation), ...
Patient record storage offered on flash drive.(PRODUCTS)
Mar 01, 2009; ... Providing an alternative for patients in storing medical records, My Critical Medical Information Plus[TM] is a system that combines the use of a secure server as well as personal flash drives that can be worn on a key chain or necklace. The advantage of the flash-drive approach ...
Integrative oncology: principles and practice.(Book review)
Mar 01, 2009; ... Integrative Oncology: Principles and Practice. Matthew P. Mumber (Ed.), London: Taylor and Francis, 2006, 517 pages, hardcover, $269.95. [ILLUSTRATION OMITTED] Integrative Oncology: Principles and Practice is one of the first comprehensive textbooks in this emerging ...
Using the Power of Hope to cope with dying: the four stages of hope.(Book review)
Mar 01, 2009; ... Using the Power of Hope to Cope With Dying: The Four Stages of Hope. Cathleen Fanslow-Brunjes. Sanger, CA: Quill Driver, 2008, 119 pages, hardcover, $25. [ILLUSTRATION OMITTED] Fanslow-Brunjes, an expert in the fields of death, dying, grief, and hospice care, ...
Nursing Ethics and Professional Responsibility in Advanced Practice.(Book review)
Mar 01, 2009; ... Nursing Ethics and Professional Responsibility in Advanced Practice. Pamela Grace. Sudbury, MA: Jones and Bartlett, 2009, 428 pages, hardcover, $59.95. Advanced practice nurses (APNs) undergo extensive intellectual, clinical, and practical training to ensure the safety of their ...
Making cancer history: disease and discovery at the University of Texas M.D. Anderson Cancer Center.(Brief article)(Book review)
Mar 01, 2009 ... Making Cancer History: Disease and Discovery at the University of Texas M.D. Anderson Cancer Center. James S. Olson. Baltimore: Johns Hopkins University Press, expected release March 2009, 408 pages, $35. The M.D. Anderson Cancer Center is one of the first medical institutions ...
Integrative oncology.(Brief article)(Book review)
Mar 01, 2009 ... Integrative Oncology. Donald Abrams and Andrew Weil. New York: Oxford University Press, 2008, 624 pages, $35. People facing a new diagnosis of cancer often are unsettled by their prognoses and treatment options and seek to integrate complementary modalities into their ...
Final Moments: nurses' stories about death and dying.(Brief article)(Book review)
Mar 01, 2009 ... Final Moments: Nurses' Stories About Death and Dying. Deborah Witt Sherman (Ed.). New York: Kaplan, 2009, $14.95. Twenty-five nurses from hospitals, private practices, and in-home health care tell about their experiences with death. New as well as experienced nurses discuss ...
Knowledge Central.
Mar 01, 2009 ... Do you have comments or a book or Web site that you would like to submit for review? Are you interested in ...
Self-care strategies to cope with taste changes after chemotherapy.(Continuing Nursing Education Article)(Report)
Mar 01, 2009; ... Chemotherapy agents can cause a wide range of adverse effects. One such cluster of manifestations that has gained greater attention in the literature is taste changes, which typically are described by severity, distress, and effects on usual activities. For instance, 38%-77% of patients ...
Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.(Online Exclusive Article)(Report)
Mar 01, 2009; ... People at risk for hereditary breast and ovarian cancer (HBOC) may consider having clinical BRCA cancer susceptibility testing to further elucidate their risk. They also may receive cancer surveillance recommendations from healthcare providers, yet little is known about their choices of ...
Patient-centered communication during oncology follow-up visits for breast cancer survivors: content and temporal structure.(Online Exclusive Article)(Report)
Mar 01, 2009; ... Many breast cancer survivors attend routine oncology-related medical office follow-up visits throughout survivorship (Clayton, Dudley, & Musters, 2008; Clayton, Mishel, & Belyea, 2006). Most of these survivors successfully adapt to survivorship and resume their daily lives without ...
Pre- and postintervention differences in acculturation, knowledge, beliefs, and stages of readiness for mammograms among Korean American women.(Online Exclusive Article)(Report)
Mar 01, 2009; ... The number of Americans with Korean ancestry in the United States is about 1.3 million, representing 0.4% of the total U.S. population. Of that population, 75% are foreign-born, 58% are women, and 42% are women aged 35 years or older (U.S. Census Bureau, 2006). Breast cancer is the most ...
Norwegian healthcare professionals' perceptions of patient knowledge and involvement as basis for decision making in hematology.(Online Exclusive Article)(Report)
Mar 01, 2009; ... Patients differ in their knowledge of illnesses and their desire to be involved in the treatment process. Some patients may be informed and make active decisions about treatment procedures (Henwood, Wyatt, Hart, & Smith, 2003), but others tend to avoid involvement (Lupton, 1997). Some ...
Consolation in conjunction with incurable cancer.(Online Exclusive Article)(Report)
Mar 01, 2009; ... Improvements in medical treatment and increased life expectancy mean more people are enduring incurable chronic diseases. About 20,000 people die each year in Sweden from a variety of cancers and, at some point during the course of their disease progression, most of the patients require ...